Evidence map›Paper›PMID 40900023›Full record

ArticleJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners2025

Excess volume addition method improves human resource efficiency and environmental sustainability of cytotoxic drug preparations.

Marie Kroemer, Guillaume Galy, Severine Tarun-Coquoz, Camille Stampfli, Pauline Thomann, Antoine Pierrot, Laurent Carrez, Farshid Sadeghipour

Abstract read
In one paragraph

Article in Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marie KroemerDepartment of Pharmacy, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.ORCID 0000-0001-9274-619X
Guillaume GalyDepartment of Pharmacy, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.ORCID 0009-0005-2645-7580
Severine Tarun-CoquozDepartment of Informatics, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Camille StampfliDepartment of Pharmacy, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Pauline ThomannDepartment of Pharmacy, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Antoine PierrotDepartment of Pharmacy, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Laurent CarrezDepartment of Pharmacy, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.ORCID 0000-0002-6546-8128
Farshid SadeghipourDepartment of Pharmacy, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.ORCID 0000-0003-0817-5393

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IntroductionThe increasing incidence of cancer entails a rising burden of cytotoxic drugs preparation. To improve the preparation process of cytotoxic drugs, specially designed half-filled bags with overfill capacity were manufactured and used in clinical routine. The aim of this study was to investigate the impact of using such bags on the duration of preparation, human resources, costs and environmental sustainability.Methods and MaterialsA retrospective study comparing two methods, volume substitution and excess volume addition, for cytotoxic drug preparations was conducted over two periods of 6 months, within a University Hospital chemotherapy production unit. Volume substitution method (period 1; 5527 preparations) corresponded to the use of filled-bags. Excess volume addition method (period 2; 5108 preparations) corresponded to the use of half-filled bags. Preparation time included drug reconstitution and gravimetric controls. Data were extracted from the BD Cato

Indexed as

Antineoplastic AgentsDrug CompoundingDrug PackagingHumansPharmacy Service, HospitalRetrospective StudiesTime FactorsAntineoplastic AgentsAntineoplastic agentsdrug compoundinghospitalpharmaceutical servicespharmacy servicesustainable developmentworkflow

Identifiers

PMID40900023
PMCPMC12605280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.